FDA Inspection 1082134 — Empire Clinical Research, LLC
The FDA completed an inspection of Empire Clinical Research, LLC on Jul 13, 2018 in Upland, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Upland, CA (United States)
Additional Details
Clinical BA/BE